| answer text |
<p>The information requested on the number of prescriptions that have been issued
for continuous glucose monitoring devices in each clinical commissioning group (CCG)
area in not collected. CCGs are responsible for commissioning and funding diabetes
services, including funding for prescriptions for continuous glucose monitoring devices,
for their local populations. CCGs are clinically led organisations that have both
the local knowledge and accountability to make commissioning and funding decisions
in the best interests of their patients.</p><p>CCGs and providers should agree a local
price for when these devices are in use, as they are not set by the national tariff
but are in the high cost devices list in the tariff for 2019/20.</p><p> </p>
|
 |
